MarketPeel
Insider Trading Intelligence
Pricing
…
ML

Michael L. Levitz

ANIK
EVP, CFO, TREASURER · ANIKA THERAPEUTICS, INC. · CIK 0001468019
FILING MIX · LIFETIME62%/38%
BUYS
23
SELLS
14
TOTAL VALUE
$512.8K
COMPANIES
1
ACTIVE SINCE
Aug 2020
HOLDINGS NOW
21,329
AVG SELL PX
$25.13
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael L. Levitz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+5.05%+1.31%+3.74%+3.93%—
14d3+100.00%+1.77%+3.17%-1.40%+1.02%—
30d3+0.00%-3.73%+1.83%-5.56%-2.75%—
60d3+33.33%-5.56%-2.82%-2.74%+1.83%—
90d3+0.00%-6.55%+2.00%-8.55%-9.11%—
180d3+0.00%-18.99%-0.38%-18.61%-25.51%—
1y3+33.33%-29.73%-4.44%-25.29%-42.22%—
2y3+33.33%-36.18%+10.77%-46.95%-58.04%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIK · 21,329 shares · as of Mar 15, 2024
014,28628,57342,85957,1452021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
FLOW · 23 buys / 14 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
51,682——51,682Mar 15, 2024Mar 19, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,329——21,329Mar 15, 2024Mar 19, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
4,438——0Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
2,610$25.79$67.3K46,955Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
5,875——11,749Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
8,888——8,888Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
1,303$25.42$33.1K36,527Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
1,725$25.42$43.8K40,677Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
5,875——42,402Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
8,888——49,565Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
4,438——37,830Mar 11, 2024Mar 12, 2024 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
3,859——0Aug 10, 2023Aug 11, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
3,859——34,365Aug 10, 2023Aug 11, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
1,133$18.58$21.1K33,232Aug 10, 2023Aug 11, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
2,609$26.10$68.1K29,838Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
8,888——32,447Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
8,888——17,776Mar 10, 2023Mar 14, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
1,303$26.91$35.1K23,559Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
4,439——4,438Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
4,439——24,862Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,475——38,475Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,624——17,624Mar 9, 2023Mar 10, 2023 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
3,859——20,423Aug 10, 2022Aug 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
3,859——3,859Aug 10, 2022Aug 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
4,000$24.62$98.5K15,924Mar 11, 2022Mar 14, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,979——38,979Mar 11, 2022Mar 15, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,664——26,664Mar 11, 2022Mar 15, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
4,438——11,924Mar 9, 2022Mar 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,438——8,877Mar 9, 2022Mar 11, 2022 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
777$40.21$31.2K7,486Aug 12, 2021Aug 13, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
2,850$40.21$114.6K6,709Aug 11, 2021Aug 13, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASE
EVP, CFO, Treasurer
3,859——3,859Aug 10, 2021Aug 12, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
SALE
EVP, CFO, Treasurer
3,859——7,718Aug 10, 2021Aug 12, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,363——33,363Mar 9, 2021Mar 11, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,315——13,315Mar 9, 2021Mar 11, 2021 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,577——11,577Aug 10, 2020Aug 12, 2020 ↗View →
ANIK
ANIKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
57,145——57,145Aug 10, 2020Aug 12, 2020 ↗View →
Other insiders · ANIK
Loading peer insiders…
About this filer
CIK 0001468019
ROLE
EVP, CFO, Treasurer
PRIMARY
ANIK
COMPANIES
1
ACTIVE SINCE
Aug 2020
MARKETPEEL · /INSIDER/0001468019DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback